460 related articles for article (PubMed ID: 32296012)
1. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
[No Abstract] [Full Text] [Related]
2. COVID-19: Stay Cool toward Corticosteroids.
Fujishima S
Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
[No Abstract] [Full Text] [Related]
3. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.
Arentz M; Yim E; Klaff L; Lokhandwala S; Riedo FX; Chong M; Lee M
JAMA; 2020 Apr; 323(16):1612-1614. PubMed ID: 32191259
[TBL] [Abstract][Full Text] [Related]
7. Understanding of COVID-19 based on current evidence.
Sun P; Lu X; Xu C; Sun W; Pan B
J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
9. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
10. Anaphylactic shock following the diagnosis of coronavirus disease 2019.
Alvarez-Perea A; Baeza ML
Ann Allergy Asthma Immunol; 2020 Oct; 125(4):477-478. PubMed ID: 32745608
[No Abstract] [Full Text] [Related]
11. The COVID-19 Pandemic and Mayo Clinic Proceedings.
Nath KA
Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
[No Abstract] [Full Text] [Related]
12. [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
Yuan X; Mu JS; Mo GX; Hu XS; Yan P; Xie LX
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):177-180. PubMed ID: 32164082
[TBL] [Abstract][Full Text] [Related]
13. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.
Arabi YM; Chrousos GP; Meduri GU
Intensive Care Med; 2020 Nov; 46(11):2067-2070. PubMed ID: 33026460
[No Abstract] [Full Text] [Related]
14. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
Kara E; Demirkan K; Unal S
Int J Antimicrob Agents; 2020 Sep; 56(3):106123. PubMed ID: 32738307
[No Abstract] [Full Text] [Related]
15. COVID-19 as a cause of immune thrombocytopenia.
Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
[No Abstract] [Full Text] [Related]
16. Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.
Assimakopoulos SF; Seintis F; Marangos M
Med Hypotheses; 2020 Oct; 143():109926. PubMed ID: 32485316
[No Abstract] [Full Text] [Related]
17. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
Yahya AS; Khawaja S; Chukwuma J
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
[No Abstract] [Full Text] [Related]
18. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.
Mastellos DC; Pires da Silva BGP; Fonseca BAL; Fonseca NP; Auxiliadora-Martins M; Mastaglio S; Ruggeri A; Sironi M; Radermacher P; Chrysanthopoulou A; Skendros P; Ritis K; Manfra I; Iacobelli S; Huber-Lang M; Nilsson B; Yancopoulou D; Connolly ES; Garlanda C; Ciceri F; Risitano AM; Calado RT; Lambris JD
Clin Immunol; 2020 Nov; 220():108598. PubMed ID: 32961333
[TBL] [Abstract][Full Text] [Related]
19. Neurologic Features in Severe SARS-CoV-2 Infection.
Helms J; Kremer S; Merdji H; Clere-Jehl R; Schenck M; Kummerlen C; Collange O; Boulay C; Fafi-Kremer S; Ohana M; Anheim M; Meziani F
N Engl J Med; 2020 Jun; 382(23):2268-2270. PubMed ID: 32294339
[No Abstract] [Full Text] [Related]
20. Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
Verrall GM
Front Immunol; 2020; 11():2167. PubMed ID: 33013911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
